Fresenius Medical Care closes $2bn NxStage Medical acquis

German dialysis products and services company Fresenius Medical Care has completed the $2bn acquisition of US-based medical devices maker NxStage Medical, after receiving clearance from the US antitrust authorities.

NxStage Medical primarily focuses on the development, production and marketing of medical devices for in-home dialysis and critical care.

The deal, first announced in August 2017, will help Fresenius Medical Care leverage its manufacturing, supply chain and marketing capabilities across the dialysis products, services and Care Coordination businesses.

Read more.

source verdict medical devices